Education
About Us
Working with TipRanks
Follow Us
Kestra Medical Technologies Ltd. (KMTS)
NASDAQ:KMTS
Earnings Data
Report Date
Apr 20, 2026After Close (Confirmed)
Period Ending
2026 (Q3)Consensus EPS Forecast
-0.6Last Year’s EPS
-1.25Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The earnings call highlighted significant growth in revenue and gross margin, supported by positive clinical study outcomes and an expanded sales force. However, the company continues to face challenges with net losses and operating expenses, along with the underpenetrated WCD market. Overall, the positive aspects of revenue growth and clinical validation outweigh the negatives.Company Guidance
Strong Revenue Growth
Revenue reached $22.6 million, marking a 53% increase over the prior year period. Prescription volumes increased by 54% year-over-year, reflecting market share gains and activation of new accounts.
Gross Margin Milestone
Gross margin surpassed 50% for the first time in the company's history, reaching 50.6%, up 11 points from the previous year. This marks the eighth consecutive quarter of gross margin expansion.
Positive Clinical Study Results
The ACE PAS study, involving over 21,000 patients, met its primary endpoints, demonstrating the safety and effectiveness of the Assure system. It also highlighted an increase in WCD wear time and a reduction in false alarms.
Increased Revenue Guidance
Fiscal year 2026 revenue guidance was increased to $91 million, representing a 52% growth compared to fiscal year 2025.
Expanded Sales Force
The company expanded its sales organization to approximately 100 active sales territories, up from about 80 at the end of fiscal year 2025.
Improved Revenue Cycle Management
The in-network mix increased to the low eighties, improving revenue cycle metrics and supporting future margin expansion.
KMTS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
KMTS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Dec 11, 2025 | $24.91 | $26.17 | +5.06% |
Sep 11, 2025 | $18.40 | $21.83 | +18.64% |
Jul 15, 2025 | $16.29 | $15.35 | -5.77% |
Apr 14, 2025 | $23.83 | $24.13 | +1.26% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Kestra Medical Technologies Ltd. (KMTS) report earnings?
Kestra Medical Technologies Ltd. (KMTS) is schdueled to report earning on Apr 20, 2026, After Close (Confirmed).
What is Kestra Medical Technologies Ltd. (KMTS) earnings time?
Kestra Medical Technologies Ltd. (KMTS) earnings time is at Apr 20, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is KMTS EPS forecast?
KMTS EPS forecast for the fiscal quarter 2026 (Q3) is -0.6.